BioMarin to Present Data Underscoring Sustained Positive Impact of VOXZOGO® (vosoritide) on Health-Related Quality of Life, Growth and Maintenance of Bone Strength in Children with Achondroplasia at 2024 International Skeletal Dysplasia Society Meeting
September 18, 2024
Stay updated.
Subscribe to our email alerts for investors to stay informed about the latest developments at BioMarin.